학술논문

EE288 Decision Model to Evaluate the Cost of Clinical Events Associated with Switching from Apixaban to Rivaroxaban Among Patients with Non-Valvular Atrial Fibrillation in Germany
Document Type
Abstract
Source
In Value in Health June 2024 27(6) Supplement:S110-S111
Subject
Language
ISSN
1098-3015